Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain

Ítems similars

• Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice
  per: Sitbon, Yoel H., et al.
  Publicat: (2020)
• Insights into myosin regulatory and essential light chains: a focus on their roles in cardiac and skeletal muscle function, development and disease
  per: Sitbon, Yoel H, et al.
  Publicat: (2019)
• Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM and DCM associated with mutations in cardiac myosin light chains
  per: Yadav, Sunil, et al.
  Publicat: (2019)
• In Vitro Rescue Study of a Malignant Familial Hypertrophic Cardiomyopathy Phenotype by Pseudo-Phosphorylation of Myosin Regulatory Light Chain
  per: Muthu, Priya, et al.
  Publicat: (2013)
• Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy
  per: Yadav, Sunil, et al.
  Publicat: (2017)